vimarsana.com

Page 24 - ஒன்றுபட்டது கிஂக்டம் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |Takeover Panel Announcements | Takeover Panel: Disclosure Table (POTAM only)

Investegate |Takeover Panel Announcements | Takeover Panel: Disclosure Table (POTAM only)
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |Takeover Panel Announcements | Takeover Panel: Disclosure Table (POTAM only)

Investegate |Takeover Panel Announcements | Takeover Panel: Disclosure Table (POTAM only)
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

4basebio UK Societas - Admission to Trading on AIM and First Day of Dealings

4basebio UK Societas - Admission to Trading on AIM and First Day of Dealings PR Newswire Admission to Trading on AIM and First Day of Dealings 4basebio UK Societas (AIM: 4BB), the specialist life sciences group focused on exploiting its intellectual property in the field of gene therapies and DNA vaccines, is pleased to announce the admission of its ordinary shares to trading on the AIM market of the London Stock Exchange. Dealings will commence at 8.00 a.m. today, Wednesday 17 February 2021, under the ticker 4BB (ISIN GB00BLD8ZL39). Upon Admission, the Company will have 12,317,473 ordinary shares in issue and a market capitalisation of approximately £14.5 million.

Investegate |Takeover Panel Announcements | Takeover Panel: Disclosure Table (POTAM only)

Investegate |Takeover Panel Announcements | Takeover Panel: Disclosure Table (POTAM only)
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.